Cargando…

Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010

BACKGROUND: China has undergone rapid demographic and epidemiological changes in the past few decades, including striking declines in fertility and child mortality and increases in life expectancy at birth. Popular discontent with the health system has led to major reforms. To help inform these refo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Gonghuan, Wang, Yu, Zeng, Yixin, Gao, George F, Liang, Xiaofeng, Zhou, Maigeng, Wan, Xia, Yu, Shicheng, Jiang, Yuhong, Naghavi, Mohsen, Vos, Theo, Wang, Haidong, Lopez, Alan D, Murray, Christopher JL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159289/
https://www.ncbi.nlm.nih.gov/pubmed/23746901
http://dx.doi.org/10.1016/S0140-6736(13)61097-1
_version_ 1783522633520775168
author Yang, Gonghuan
Wang, Yu
Zeng, Yixin
Gao, George F
Liang, Xiaofeng
Zhou, Maigeng
Wan, Xia
Yu, Shicheng
Jiang, Yuhong
Naghavi, Mohsen
Vos, Theo
Wang, Haidong
Lopez, Alan D
Murray, Christopher JL
author_facet Yang, Gonghuan
Wang, Yu
Zeng, Yixin
Gao, George F
Liang, Xiaofeng
Zhou, Maigeng
Wan, Xia
Yu, Shicheng
Jiang, Yuhong
Naghavi, Mohsen
Vos, Theo
Wang, Haidong
Lopez, Alan D
Murray, Christopher JL
author_sort Yang, Gonghuan
collection PubMed
description BACKGROUND: China has undergone rapid demographic and epidemiological changes in the past few decades, including striking declines in fertility and child mortality and increases in life expectancy at birth. Popular discontent with the health system has led to major reforms. To help inform these reforms, we did a comprehensive assessment of disease burden in China, how it changed between 1990 and 2010, and how China's health burden compares with other nations. METHODS: We used results of the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) for 1990 and 2010 for China and 18 other countries in the G20 to assess rates and trends in mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE). We present results for 231 diseases and injuries and for 67 risk factors or clusters of risk factors relevant to China. We assessed relative performance of China against G20 countries (significantly better, worse, or indistinguishable from the G20 mean) with age-standardised rates and 95% uncertainty intervals. FINDINGS: The leading causes of death in China in 2010 were stroke (1·7 million deaths, 95% UI 1·5–1·8 million), ischaemic heart disease (948 700 deaths, 774 500–1 024 600), and chronic obstructive pulmonary disease (934 000 deaths, 846 600–1 032 300). Age-standardised YLLs in China were lower in 2010 than all emerging economies in the G20, and only slightly higher than noted in the USA. China had the lowest age-standardised YLD rate in the G20 in 2010. China also ranked tenth (95% UI eighth to tenth) for HALE and 12th (11th to 13th) for life expectancy. YLLs from neonatal causes, infectious diseases, and injuries in children declined substantially between 1990 and 2010. Mental and behavioural disorders, substance use disorders, and musculoskeletal disorders were responsible for almost half of all YLDs. The fraction of DALYs from YLDs rose from 28·1% (95% UI 24·2–32·5) in 1990 to 39·4% (34·9–43·8) in 2010. Leading causes of DALYs in 2010 were cardiovascular diseases (stroke and ischaemic heart disease), cancers (lung and liver cancer), low back pain, and depression. Dietary risk factors, high blood pressure, and tobacco exposure are the risk factors that constituted the largest number of attributable DALYs in China. Ambient air pollution ranked fourth (third to fifth; the second highest in the G20) and household air pollution ranked fifth (fourth to sixth; the third highest in the G20) in terms of the age-standardised DALY rate in 2010. INTERPRETATION: The rapid rise of non-communicable diseases driven by urbanisation, rising incomes, and ageing poses major challenges for China's health system, as does a shift to chronic disability. Reduction of population exposures from poor diet, high blood pressure, tobacco use, cholesterol, and fasting blood glucose are public policy priorities for China, as are the control of ambient and household air pollution. These changes will require an integrated government response to improve primary care and undertake required multisectoral action to tackle key risks. Analyses of disease burden provide a useful framework to guide policy responses to the changing disease spectrum in China. FUNDING: Bill & Melinda Gates Foundation.
format Online
Article
Text
id pubmed-7159289
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71592892020-04-16 Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 Yang, Gonghuan Wang, Yu Zeng, Yixin Gao, George F Liang, Xiaofeng Zhou, Maigeng Wan, Xia Yu, Shicheng Jiang, Yuhong Naghavi, Mohsen Vos, Theo Wang, Haidong Lopez, Alan D Murray, Christopher JL Lancet Article BACKGROUND: China has undergone rapid demographic and epidemiological changes in the past few decades, including striking declines in fertility and child mortality and increases in life expectancy at birth. Popular discontent with the health system has led to major reforms. To help inform these reforms, we did a comprehensive assessment of disease burden in China, how it changed between 1990 and 2010, and how China's health burden compares with other nations. METHODS: We used results of the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) for 1990 and 2010 for China and 18 other countries in the G20 to assess rates and trends in mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE). We present results for 231 diseases and injuries and for 67 risk factors or clusters of risk factors relevant to China. We assessed relative performance of China against G20 countries (significantly better, worse, or indistinguishable from the G20 mean) with age-standardised rates and 95% uncertainty intervals. FINDINGS: The leading causes of death in China in 2010 were stroke (1·7 million deaths, 95% UI 1·5–1·8 million), ischaemic heart disease (948 700 deaths, 774 500–1 024 600), and chronic obstructive pulmonary disease (934 000 deaths, 846 600–1 032 300). Age-standardised YLLs in China were lower in 2010 than all emerging economies in the G20, and only slightly higher than noted in the USA. China had the lowest age-standardised YLD rate in the G20 in 2010. China also ranked tenth (95% UI eighth to tenth) for HALE and 12th (11th to 13th) for life expectancy. YLLs from neonatal causes, infectious diseases, and injuries in children declined substantially between 1990 and 2010. Mental and behavioural disorders, substance use disorders, and musculoskeletal disorders were responsible for almost half of all YLDs. The fraction of DALYs from YLDs rose from 28·1% (95% UI 24·2–32·5) in 1990 to 39·4% (34·9–43·8) in 2010. Leading causes of DALYs in 2010 were cardiovascular diseases (stroke and ischaemic heart disease), cancers (lung and liver cancer), low back pain, and depression. Dietary risk factors, high blood pressure, and tobacco exposure are the risk factors that constituted the largest number of attributable DALYs in China. Ambient air pollution ranked fourth (third to fifth; the second highest in the G20) and household air pollution ranked fifth (fourth to sixth; the third highest in the G20) in terms of the age-standardised DALY rate in 2010. INTERPRETATION: The rapid rise of non-communicable diseases driven by urbanisation, rising incomes, and ageing poses major challenges for China's health system, as does a shift to chronic disability. Reduction of population exposures from poor diet, high blood pressure, tobacco use, cholesterol, and fasting blood glucose are public policy priorities for China, as are the control of ambient and household air pollution. These changes will require an integrated government response to improve primary care and undertake required multisectoral action to tackle key risks. Analyses of disease burden provide a useful framework to guide policy responses to the changing disease spectrum in China. FUNDING: Bill & Melinda Gates Foundation. Elsevier Ltd. 2013 2013-06-07 /pmc/articles/PMC7159289/ /pubmed/23746901 http://dx.doi.org/10.1016/S0140-6736(13)61097-1 Text en Copyright © 2013 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Yang, Gonghuan
Wang, Yu
Zeng, Yixin
Gao, George F
Liang, Xiaofeng
Zhou, Maigeng
Wan, Xia
Yu, Shicheng
Jiang, Yuhong
Naghavi, Mohsen
Vos, Theo
Wang, Haidong
Lopez, Alan D
Murray, Christopher JL
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
title Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
title_full Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
title_fullStr Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
title_full_unstemmed Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
title_short Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
title_sort rapid health transition in china, 1990–2010: findings from the global burden of disease study 2010
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159289/
https://www.ncbi.nlm.nih.gov/pubmed/23746901
http://dx.doi.org/10.1016/S0140-6736(13)61097-1
work_keys_str_mv AT yanggonghuan rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT wangyu rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT zengyixin rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT gaogeorgef rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT liangxiaofeng rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT zhoumaigeng rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT wanxia rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT yushicheng rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT jiangyuhong rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT naghavimohsen rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT vostheo rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT wanghaidong rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT lopezaland rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010
AT murraychristopherjl rapidhealthtransitioninchina19902010findingsfromtheglobalburdenofdiseasestudy2010